These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


368 related items for PubMed ID: 17400844

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Effectiveness of risedronate in osteoporotic postmenopausal women with inflammatory bowel disease: a prospective, parallel, open-label, two-year extension study.
    Palomba S, Manguso F, Orio F, Russo T, Oppedisano R, Sacchinelli A, Falbo A, Tolino A, Zullo F, Mastrantonio P.
    Menopause; 2008; 15(4 Pt 1):730-6. PubMed ID: 18698280
    [Abstract] [Full Text] [Related]

  • 24. Absolute fracture risk assessment using lumbar spine and femoral neck bone density measurements: derivation and validation of a hybrid system.
    Leslie WD, Lix LM, Manitoba Bone Density Program.
    J Bone Miner Res; 2011 Mar; 26(3):460-7. PubMed ID: 20839285
    [Abstract] [Full Text] [Related]

  • 25. Transition from estrogen-progestin to raloxifene in postmenopausal women: effect on vasomotor symptoms.
    Gordon S, Walsh BW, Ciaccia AV, Siddhanti S, Rosen AS, Plouffe L.
    Obstet Gynecol; 2004 Feb; 103(2):267-73. PubMed ID: 14754694
    [Abstract] [Full Text] [Related]

  • 26. Risk factors related to the presence and severity of hot flushes in mid-aged Ecuadorian women.
    Chedraui P, Aguirre W, Calle A, Hidalgo L, León-León P, Miranda O, Martínez N, Mendoza M, Narváez J, Sánchez H, Schwager G, Quintero JC, Zambrano B, Aguilar A, Martínez MA, Rivera R, Ruilova I.
    Maturitas; 2010 Apr; 65(4):378-82. PubMed ID: 20031350
    [Abstract] [Full Text] [Related]

  • 27. Risk factors for clinical fractures among postmenopausal women: a 10-year prospective study.
    van Geel TA, Geusens PP, Nagtzaam IF, van der Voort DJ, Schreurs CM, Rinkens PE, Dinant GJ.
    Menopause Int; 2007 Sep; 13(3):110-5. PubMed ID: 17785036
    [Abstract] [Full Text] [Related]

  • 28. Two to three years of hormone replacement treatment in healthy women have long-term preventive effects on bone mass and osteoporotic fractures: the PERF study.
    Bagger YZ, Tankó LB, Alexandersen P, Hansen HB, Møllgaard A, Ravn P, Qvist P, Kanis JA, Christiansen C.
    Bone; 2004 Apr; 34(4):728-35. PubMed ID: 15050905
    [Abstract] [Full Text] [Related]

  • 29. Osteoarthritis, bone density, postural stability, and osteoporotic fractures: a population based study.
    Jones G, Nguyen T, Sambrook PN, Lord SR, Kelly PJ, Eisman JA.
    J Rheumatol; 1995 May; 22(5):921-5. PubMed ID: 8587083
    [Abstract] [Full Text] [Related]

  • 30. Cytochrome gene polymorphisms, serum estrogens, and hot flushes in midlife women.
    Visvanathan K, Gallicchio L, Schilling C, Babus JK, Lewis LM, Miller SR, Zacur H, Flaws JA.
    Obstet Gynecol; 2005 Dec; 106(6):1372-81. PubMed ID: 16319265
    [Abstract] [Full Text] [Related]

  • 31. Changes in bone mineral density are correlated with bone markers and reductions in hot flush severity in postmenopausal women treated with bazedoxifene/conjugated estrogens.
    Gallagher JC, Shi H, Mirkin S, Chines AA.
    Menopause; 2013 Nov; 20(11):1126-32. PubMed ID: 23632659
    [Abstract] [Full Text] [Related]

  • 32. Recency and duration of postmenopausal hormone therapy: effects on bone mineral density and fracture risk in the National Osteoporosis Risk Assessment (NORA) study.
    Barrett-Connor E, Wehren LE, Siris ES, Miller P, Chen YT, Abbott TA, Berger ML, Santora AC, Sherwood LM.
    Menopause; 2003 Nov; 10(5):412-9. PubMed ID: 14501602
    [Abstract] [Full Text] [Related]

  • 33. Bisphosphonate dose and incidence of fractures in postmenopausal osteoporosis.
    Makras P, Hamdy NA, Zwinderman AH, Ballieux BE, Papapoulos SE.
    Bone; 2009 May; 44(5):766-71. PubMed ID: 19442613
    [Abstract] [Full Text] [Related]

  • 34. Estrogen-dependent increase in bone turnover and bone loss in postmenopausal women with breast cancer treated with anastrozole. Prevention with bisphosphonates.
    Confavreux CB, Fontana A, Guastalla JP, Munoz F, Brun J, Delmas PD.
    Bone; 2007 Sep; 41(3):346-52. PubMed ID: 17618847
    [Abstract] [Full Text] [Related]

  • 35. Pattern of bone loss in surgical menopause: a preliminary report.
    Chittacharoen A, Theppisai U, Sirisriro R, Thanantaseth C.
    J Med Assoc Thai; 1997 Nov; 80(11):731-7. PubMed ID: 9385771
    [Abstract] [Full Text] [Related]

  • 36. Effect of microdose transdermal 17beta-estradiol compared with raloxifene in the prevention of bone loss in healthy postmenopausal women: a 2-year, randomized, double-blind trial.
    Schaefers M, Muysers C, Alexandersen P, Christiansen C.
    Menopause; 2009 Nov; 16(3):559-65. PubMed ID: 19423999
    [Abstract] [Full Text] [Related]

  • 37. The burden of prevalent fractures on health-related quality of life in postmenopausal women with osteoporosis: the IMOF study.
    Salaffi F, Cimmino MA, Malavolta N, Carotti M, Di Matteo L, Scendoni P, Grassi W, Italian Multicentre Osteoporotic Fracture Study Group.
    J Rheumatol; 2007 Jul; 34(7):1551-60. PubMed ID: 17516618
    [Abstract] [Full Text] [Related]

  • 38. The relationship between serum adiponectin level and anthropometry, bone mass, osteoporotic fracture risk in postmenopausal women.
    Ozkurt B, Ozkurt ZN, Altay M, Aktekin CN, Cağlayan O, Tabak Y.
    Eklem Hastalik Cerrahisi; 2009 Jul; 20(2):78-84. PubMed ID: 19619110
    [Abstract] [Full Text] [Related]

  • 39. Relation of alleles of the collagen type Ialpha1 gene to bone density and the risk of osteoporotic fractures in postmenopausal women.
    Uitterlinden AG, Burger H, Huang Q, Yue F, McGuigan FE, Grant SF, Hofman A, van Leeuwen JP, Pols HA, Ralston SH.
    N Engl J Med; 1998 Apr 09; 338(15):1016-21. PubMed ID: 9535665
    [Abstract] [Full Text] [Related]

  • 40. Effects of bazedoxifene in nonflushing postmenopausal women: a randomized phase 2 trial.
    Bachmann G, Crosby U, Feldman RA, Ronkin S, Constantine GD.
    Menopause; 2011 May 09; 18(5):508-14. PubMed ID: 21289525
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 19.